Recently, engineered Csrp3/Mlp−/− induced pluripotent stem cell-derived cardiomyocytes were shown to develop a hypertrophic and HF phenotype due to abnormal Ca2+ handling which could be improved by exposure to a L-type Ca2+ channel blocker43. This evidence concerns the gene CSRP3 and hydrops fetalis.